| Serial Number | 97034358 |
| Word Mark | WUXI XDC THE BIOCONJUGATION LEADER |
| Filing Date | Saturday, September 18, 2021 |
| Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
| Status Date | Monday, June 10, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, September 13, 2022 |
| Description of Mark | The mark consists of the stylized wordings "WUXI" over "XDC", partially inside an incomplete oval outline that intersects with another incomplete oval outline. Below these appears the wording "THE BIOCONJUGATION LEADER" in stylized font. |
| Goods and Services | Pharmaceutical preparations for the treatment of cancer, infectious disease, metabolic disease, and central nervous system disease; chemico-pharmaceutical preparations for the treatment of cancer, infectious disease, metabolic disease, and central nervous system disease; drugs for medical purposes, namely, anticancer preparations; biological preparations for the treatment of cancer, infectious disease, metabolic disease, and central nervous system disease; chemical preparations for pharmaceutical or medical purposes, namely, for the treatment of cancer, infectious disease, metabolic disease, and central nervous system disease; medicines for human purposes for the treatment of cancer, infectious disease, metabolic disease, and central nervous system disease; medicines for human purposes in the nature of bioconjugate preparations for the treatment of cancer, infectious disease, metabolic disease, and central nervous system disease; pharmaceutical preparations, substances and compositions, namely, antibody-drug conjugates in the nature of medical diagnostic reagents; pharmaceutical preparations, namely, drug conjugates consisting primarily of pharmaceutical preparations for the treatment of cancer, infectious disease, metabolic disease, and central nervous system disease |
| NOT AVAILABLE | "WUXI" OR "BIOCONJUGATION" |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, October 22, 2021 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | WuXi XDC Cayman Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Wuxi, Jiangsu Province 214028 CN |
| Party Name | WuXi XDC Cayman Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Wuxi, Jiangsu Province 214028 CN |
| Event Date | Event Description |
| Saturday, October 23, 2021 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Wednesday, September 22, 2021 | NEW APPLICATION ENTERED |
| Friday, October 22, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, June 22, 2022 | ASSIGNED TO EXAMINER |
| Tuesday, June 28, 2022 | EXAMINERS AMENDMENT -WRITTEN |
| Tuesday, June 28, 2022 | EXAMINERS AMENDMENT E-MAILED |
| Tuesday, June 28, 2022 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Tuesday, June 28, 2022 | EXAMINER'S AMENDMENT ENTERED |
| Tuesday, September 13, 2022 | PUBLISHED FOR OPPOSITION |
| Tuesday, August 9, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, August 24, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, September 13, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, November 8, 2022 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Friday, May 5, 2023 | SOU TEAS EXTENSION RECEIVED |
| Friday, May 5, 2023 | TEAS REQUEST TO DIVIDE RECEIVED |
| Friday, May 5, 2023 | DIVISIONAL REQUEST RECEIVED |
| Friday, May 5, 2023 | SOU EXTENSION 1 FILED |
| Tuesday, May 30, 2023 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Thursday, June 1, 2023 | DIVISIONAL PROCESSING COMPLETE |
| Thursday, June 1, 2023 | SOU EXTENSION 1 GRANTED |
| Friday, June 2, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Friday, June 2, 2023 | CORRECTED NOA E-MAILED |
| Thursday, October 26, 2023 | SOU TEAS EXTENSION RECEIVED |
| Thursday, October 26, 2023 | SOU EXTENSION 2 FILED |
| Thursday, October 26, 2023 | SOU EXTENSION 2 GRANTED |
| Saturday, October 28, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, June 10, 2024 | ABANDONMENT - NO USE STATEMENT FILED |
| Friday, July 12, 2024 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |